P073 ADEQUATELY DOSED 6-TG USE IN CHRONIC INTESTINAL INFLAMMATION IS NOT ASSOCIATED WITH NODULAR REGENERATIVE HYPERPLASIA: A SERIES OF 73 LIVER BIOPSIES

Bindia Jharap(Meander Medisch Centrum), Nanne K.H. de Boer, B. D. Westerveld(Isala), C. J. J. Mulder(Amsterdam UMC Location Vrije Universiteit Amsterdam), G. den Hartog(Rijnstate Hospital), Ad A. van Bodegraven(Vrije Universiteit Amsterdam), L.G.J.B. Engels(Faculdade de Medicina de Jundiaí), Dirk J. de Jong(Radboud University Nijmegen)
Journal of Crohn s and Colitis Supplements
March 1, 2007
10.1016/s1873-9954(07)70085-x
Cited by 0

Related Papers

Loss of Response to Anti-TNFs: Definition, Epidemiology, and Management
|Clinical and Translational Gastroenterology|2016|724
Genome-wide association identifies multiple ulcerative colitis susceptibility loci
|Nature Genetics|2010|680
Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial
|The Lancet|2022|301
Circulating Vα24+ Vβ11+ NKT Cell Numbers Are Decreased in a Wide Variety of Diseases That Are Characterized by Autoreactive Tissue Damage
|Clinical Immunology|2001|270
Infants born to mothers with IBD present with altered gut microbiome that transfers abnormalities of the adaptive immune system to germ-free mice
|Gut|2019|221